Preclinical Medical Device Testing Services Market Snapshot (2022-2032)

[300 Pages Report] The global preclinical medical device testing services market garnered a market value of US$ 2.8 Billion in 2022 and is expected to accumulate a market value of US$ 6.63 Billion by registering a CAGR of 9% in the forecast period 2022-2032. Growth of the preclinical medical device testing services market can be attributed to escalating product complexity and strict governmental regulations. The market for preclinical medical device testing services registered a CAGR of 5.5% in the historical period 2017 to 2021.

One of the main factors propelling the market is the rising demand for technologically advanced medical devices. The COVID-19 pandemic has created an unheard-of surge in demand in 2020 for medical device testing services and this pattern was anticipated to continue in 2021 due to the urgent need for medical devices, numerous medical device manufacturers worldwide developed new COVID-19 testing devices. This is likely to have a positive impact on the market.

Data Points Key Statistics
Expected Market Value of Preclinical Medical Device Testing Services in 2022 US$ 2.8 Billion
Projected Market Value of Preclinical Medical Device Testing Services in 2032 US$ 6.63 Billion
Growth Rate (2022 to 2032) 9% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2017-2021 Preclinical Medical Device Testing Services Market Demand Analysis vs. Forecast 2022-2032

According to market research and competitive intelligence provider Future Market Insights- the market for preclinical medical device testing services registered a CAGR of 5.5% in the historical period 2017-2021.

Modern preclinical testing continues to depend heavily on animal testing. Even though the morality of using animals in medical testing is still hotly contested, it is a global practice widely accepted and remains a common research methodology used by teams looking into a variety of human diseases. A new drug or vaccine must go through preclinical testing to establish its safety and efficacy before being tested on humans. These tests typically take the form of either in vitro experiments utilizing cultures of human cells or animal experiments using various species of animals to provide a model as to how the novel therapeutic substance could impact a human subject.

The manufacturers emphasize developing new medical devices based on the high prevalence of diseases. Medical device product development and design is a complex process. The demand for preclinical medical device testing services is likely to rise as a result of the high complexity of medical device design and the prevalence of chronic diseases.

For instance, by 2020, the prevalence of chronic diseases was predicted to increase by 57%, according to the World Health Organization. Since population growth is expected to be most significant in developing countries, emerging markets would be the hardest hit. As a result, the demand for preclinical medical device testing services market is expected to register a CAGR of 9% in the assessment period 2022-2032.

Which are Some Prominent Drivers of Preclinical Medical Device Testing Services Market?

Advancements in technology bolstering the use of Preclinical Medical Device Testing Services

Medical devices have improved due to technological advancements over time. IoT and AI are already included in medical devices. Additionally, in order to maintain their position as market leaders, the players in the industry are eager to implement cutting-edge medical devices. Therefore, demand for preclinical medical device testing services is predicted as a result of such initiatives.

Preclinical medical device trials were not concentrated on treating and diagnosing diseases associated with cardiovascular, cancer, and other diseases during the COVID-19 pandemic due to the virus's widespread distribution throughout the world at the time. In certain ways, this had slowed the market. But in order to stop the spread of the pandemic, there was a pressing need for PPE masks, kits, IVD kits, and other tools.

The emergence of medical devices for the diagnosis and treatment of COVID-19 was eagerly anticipated by public organizations. For instance, the COVID-19 Breathalyzer Test was developed by researchers at Rutgers with funding from the NIH of US$ 443,000 in April 2021. Hence, such initiatives are expected to have a positive impact on the market.

Extensive Sterilization of Medical Equipment to encourage uptake of Preclinical Medical Device Testing Services

The demand for medical devices and the need for sterilization is rising necessitating the use of all sterilization methods. The majority of single-use medical devices are made of polymers that can only withstand a slight rise in temperature. The two main "cold" sterilization techniques have been ethylene oxide and gamma radiation for several years. Since the 1970s, medical device sterilizations with electron beams have advanced.

As the demand for contract electron beam irradiation increased, many large medical device manufacturers are now using electron beam accelerators as an internal sterilization solution. The first high-power X-ray sterilization facility in Switzerland, presently owned by STERIS, began operating in 2011. Since 2020, newer EB-X service facilities have opened than new gamma facilities. The new X-ray capacity has been built or is being constructed in the U.S., Germany, Netherlands, and Thailand.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Preclinical Medical Device Testing Services Market?

Expensive licensing procedures affecting market growth

While promoting standards and control of medical devices is essential, excessive regulations, especially in a domestic context, can impede the local innovation of these devices. It can impede domestic innovation by subjecting new technologies to a lengthy and costly licencing procedure, thereby increasing the time and money local manufacturers must spend and the cost of manufacturing medical equipment.

Due to the perceived risks associated with their use, a few products of great value to low-income countries may be removed from the market. This, in turn, is restraining the market growth of preclinical medical device testing services market.

Region-Wise Insights

Established Players keen interest in taking FDA Approvals Increasing Product Portfolio for Key Manufacturers in North America?

Research and expansion of products bolstering market growth in North America

North America is expected to be the dominant market share holder for preclinical medical device testing services market. This is owing to the strong healthcare sector along with presence of established players in the region. In addition, key players are undertaking research and are keen on taking approval from the FDA to expand product portfolio.

Moreover, an increase in the patient pool along with technology advancements in the field of healthcare is positively influencing the growth of the market. Thus, North America is expected to dominate the market for preclinical medical device testing services with the largest revenue share of 38% in 2022.

Increasing Patient Pool Augmenting Growth of Preclinical Medical Device Testing Services in Asia Pacific?

Technological integration advancing growth of preclinical medical device testing services market

The Asia Pacific region is the hotspot of patients owing to the increasing number of populations that comprises of geriatric population. The increasing dependency on testing services by nearly all age groups for taking treatments on time is fueling the growth of preclinical medical device testing services market.

Moreover, developing regions such as India and South Korea along with developed region like China is constantly innovating and integrating technology to cater to a wide pool of medical requirements. Furthermore, the increasing dependency on testing device services by healthcare professionals is augmenting the growth of preclinical medical device testing services market. The Asia Pacific is expected to rise with the fastest growth of 8.5% in the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

County-Wise Analysis

Cost-Effective Healthcare Sectors Driving Demand for Preclinical Medical Device Testing Services in the U.S?

Strong presence of established players shaping preclinical medical testing services market in North America

The presence of established players in the North American region is a primary factor contributing to the growth of the market. U.S., specifically serves as a premier manufacturing hub for expensive medical devices and sophisticated highly dependable tools. In addition, there is a rapid increase in the manufacturing of medical devices to meet the rising demand for efficient and cost-effective healthcare in this region.

Moreover, the rise in demand for cutting-edge medical devices and the availability of sophisticated infrastructure for developing complex, highly dependable, and high-end medical devices. In addition, the FDA policies are promoting the expansion of the market for medical device testing services in the country. All these factors are contributing to the growth of the preclinical medical device testing services.

Inexpensive Outsourcing Favoring Growth of Preclinical Medical Device Testing Services in India?

Favorable Policies opening Opportunistic Doors for Preclinical Medical Device Testing Services in India

One of the key factors fueling the regional market is the low cost of outsourcing medical device testing services in India. The region's rise in disease burden and the growing demand for advanced medical devices are both driving the market expansion.

Furthermore, the rising demand for medical devices and favorable policies in India & China is driving the growth. For instance, the Government of India strengthened trade policies in October 2021 that enable Indian medical devices to get international acceptance in the global market. This regulation would drive the demand for testing services in India and the rest of the world.

Category-Wise Insights

Accurate Determination of Microorganisms Influencing Usage of Microbiology and Sterility Tests?

Mandatory requirements for testing boosting usage of Microbiology and Sterility Tests

Microbiology & sterility testing is one of the major tests included in pre-clinical medical device testing. These examinations aid in identifying any microorganisms that could be present in the apparatus. This test can be used to determine whether bacteria, fungi, or yeasts are present in medical devices in a viable form. For validation purposes, the FDA and other regulatory bodies demand these tests. Also, as a part of routine quality control, these tests are carried out.

Based on the test type of microbiology & sterility testing segment is further classified into bioburden determination, pyrogen & endotoxin testing, sterility test & validation, antimicrobial activity testing, and others. Among them, the sterility test & validation segment is further narrowed down into ethylene oxide (EO) gas sterilization, gamma-irradiation, E-beam sterilization, and X-ray sterilization.

The sterilization method must be validated by the manufacturers of sterile devices or of devices that would be cleaned and sterilized in between uses. Steam sterilization is the most frequent method of sterilization followed by hospitals as a standard sterilization procedure and it is not well-liked by companies that produce medical devices. Since almost all materials can be safely sterilized with Ethylene Oxide EO gas, manufacturers frequently use this method. However, the radiation can result in material degradation (cracks) and discoloration. Gamma-irradiation is also frequently used. Other techniques exist, such as E-beam sterilization also play a marginal role. The microbiology & sterility testing segment accounted for the maximum revenue share of 35% in 2022.

Inclusion of wide variety of products making Chemistry Test a Viable Option?

Designing of Medical Devices driving the growth of Chemistry Test Segment

Chemical testing is done for characterizing, identifying, and comprehending the chemicals used for manufacturing medical devices. Chemical testing complies with the ISO 10993-17 and 10993-18T regulations. According to the biocompatibility standards, it is a requirement for all medical devices to obtain chemical information, which results in chemical characterization for the majority of medical devices.

From low-risk items like medical spatulas and disinfectants to high-risk items like implants and cardiac pacemakers, this category includes a wide variety of products. Manufacturers could anticipate potential toxicities and take precautions against them by analyzing the chemicals that commute from the device to the patient. The complexities associated with the designing of medical devices are driving the segment growth. Thus, the chemistry test segment is expected to rise with the fastest CAGR of 9.0% in the forecast period.

Start-Ups for Preclinical Medical Device Testing Services Market

Key start-up players in the Preclinical Medical Device Testing Services Market are Proov, Senzo, Garwood Medical Devices and Parasym Health.

  • Proov, a key start-up player in the preclinical medical device testing services market is focusing on offering test strips that help women in detecting progesterone levels. Thorough this, the company is providing information to women that could otherwise be only acquired with blood tests.
  • Senzo, another key start-up player in the preclinical medical device testing services market has developed amplified lateral flow rapid antigen self-test for COVID-19. In July 2022, the company announced that it is planning to bring the tests through regulatory approvals.

Market Competition

Key players in the preclinical medical device testing services market are SGS SA, Eurofins Scientific, PaxeraHealth Intertek Group Plc, WUXI APPTEC, TÜV SÜD AG, Sterigenics International LLC, EAS Group, Labcorp, Nelson Labs, North American Science Associates, Inc, Charles River Laboratories International Inc and Pace Analytical Services LLC

  • In June 2022, SGS SA announced the acquisition of proderm, the leading provider of advanced clinical testing solutions for cosmetics, personal care and medical products in Germany. Founded in 1994, proderm is headquartered in Hamburg, with two additional locations in Germany, and serves clients in the global consumer care and pharmaceutical industries.
  • In August 2021, an AI-based imaging platform was introduced in the U.S. by PaxeraHealth, a company that offers imaging health.

Report Scope

Report Attributes Details
Market Value in 2022 US$ 2.8 Billion
Market Value in 2032 US$ 6.63 Billion
Growth Rate CAGR of 9% from 2022 to 2032
Base Year for Estimation 2021
Historical Data 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in US$ Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
  • Service
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • South Africa
  • Saudi Arabia
  • U.A.E
  • Israel
Key Companies Profiled
  • SGS SA
  • Eurofins Scientific
  • Intertek Group Plc
  • WUXI APPTEC
  • TÜV SÜD AG
  • Sterigenics International LLC
  • Nelson Labs
  • North American Science Associates Inc.
  • Charles River Laboratories International Inc.
  • Pace Analytical Services LLC
Customization Available Upon Request

Key Segments Profiled in the Preclinical Medical Device Testing Services Industry Survey

Preclinical Medical Device Testing Services by Service:

  • Biocompatibility Tests
  • Chemistry Test
  • Microbiology & Sterility Testing
    • Bioburden Determination
    • Pyrogen & Endotoxin Testing
    • Sterility Test and Validation
      • Ethylene Oxide (EO) gas sterilization
      • Gamma-irradiation
      • E-beam Sterilization
      • X-ray Sterilization
      • Antimicrobial Activity Testing
      • Others
  • Package Validation

Preclinical Medical Device Testing Services by Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Frequently Asked Questions

At what rate did the preclinical medical device testing services market flourish from 2017-2021?

From 2017-2021, the preclinical medical device testing services market grew at a CAGR of 5.5%

What will be the growth rate of the global preclinical medical device testing services market during the forecast period?

The global preclinical medical device testing services market is expected to grow with a 9% CAGR during 2022-2032.

What will be the projected market size of the preclinical medical device testing services market by 2032?

As of 2032, the preclinical medical device testing services market is expected to reach US$ 6.3 Billion

Which segment is expected to dominate the global preclinical medical device testing services market during 2022?

Microbiology & sterility testing segment is expected to account for revenue share of 35% in 2022.

How is the North American preclinical medical device testing services market projected to grow in 2022?

North America is expected to dominate the market for preclinical medical device testing services with the largest revenue share of 38% in 2022.

What was the outlook of the Asia Pacific preclinical medical device testing services market during 2022?

The Asia Pacific is expected to rise with the fastest growth of 8.5% in the forecast period.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Service

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Service, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service, 2022-2032

        5.3.1. Biocompatibility Tests

        5.3.2. Chemistry Test

        5.3.3. Microbiology & Sterility Testing

            5.3.3.1. Bioburden Determination

            5.3.3.2. Pyrogen & Endotoxin Testing

            5.3.3.3. Sterility Test and Validation

                5.3.3.3.1. Ethylene Oxide Gas Sterilization

                5.3.3.3.2. Gamma-irradiation

                5.3.3.3.3. E-beam Sterilization

                5.3.3.3.4. X-ray Sterilization

            5.3.3.4. Antimicrobial Activity Testing

            5.3.3.5. Others

        5.3.4. Package Validation

    5.4. Y-o-Y Growth Trend Analysis By Service, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Service, 2022-2032

6. Global Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Europe

        6.3.4. Asia Pacific

        6.3.5. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        7.2.1. By Country

            7.2.1.1. U.S.

            7.2.1.2. Canada

        7.2.2. By Service

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By Service

    7.4. Key Takeaways

8. Latin America Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By Service

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Service

    8.4. Key Takeaways

9. Europe Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. U.K.

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Russia

            9.2.1.7. Rest of Europe

        9.2.2. By Service

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Service

    9.4. Key Takeaways

10. Asia Pacific Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. China

            10.2.1.2. Japan

            10.2.1.3. India

            10.2.1.4. South Korea

            10.2.1.5. Australia

            10.2.1.6. Rest of APAC

        10.2.2. By Service

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Service

    10.4. Key Takeaways

11. Middle East and Africa Preclinical Medical Device Testing Services Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. South Africa

            11.2.1.2. Saudi Arabia

            11.2.1.3. UAE

            11.2.1.4. Israel

            11.2.1.5. Rest of MEA

        11.2.2. By Service

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Service

    11.4. Key Takeaways

12. Key Countries Preclinical Medical Device Testing Services Market Analysis

    12.1. U.S.

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2021

            12.1.2.1. By Service

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2021

            12.2.2.1. By Service

    12.3. Brazil

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2021

            12.3.2.1. By Service

    12.4. Mexico

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2021

            12.4.2.1. By Service

    12.5. Germany

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2021

            12.5.2.1. By Service

    12.6. U.K.

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2021

            12.6.2.1. By Service

    12.7. France

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2021

            12.7.2.1. By Service

    12.8. Spain

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2021

            12.8.2.1. By Service

    12.9. Italy

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2021

            12.9.2.1. By Service

    12.10. Russia

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2021

            12.10.2.1. By Service

    12.11. China

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2021

            12.11.2.1. By Service

    12.12. Japan

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2021

            12.12.2.1. By Service

    12.13. India

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2021

            12.13.2.1. By Service

    12.14. South Korea

        12.14.1. Pricing Analysis

        12.14.2. Market Share Analysis, 2021

            12.14.2.1. By Service

    12.15. Australia

        12.15.1. Pricing Analysis

        12.15.2. Market Share Analysis, 2021

            12.15.2.1. By Service

    12.16. South Africa

        12.16.1. Pricing Analysis

        12.16.2. Market Share Analysis, 2021

            12.16.2.1. By Service

    12.17. Saudi Arabia

        12.17.1. Pricing Analysis

        12.17.2. Market Share Analysis, 2021

            12.17.2.1. By Service

    12.18. UAE

        12.18.1. Pricing Analysis

        12.18.2. Market Share Analysis, 2021

            12.18.2.1. By Service

    12.19. Israel

        12.19.1. Pricing Analysis

        12.19.2. Market Share Analysis, 2021

            12.19.2.1. By Service

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Service

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. SGS SA

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

        14.1.2. Eurofins Scientific

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

        14.1.3. Intertek Group Plc

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

        14.1.4. WUXI APPTEC

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

        14.1.5. TÜV SÜD AG

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

        14.1.6. Sterigenics International LLC

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

        14.1.7. Nelson Labs

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

        14.1.8. North American Science Associates, Inc.

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

        14.1.9. Charles River Laboratories International Inc.

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

        14.1.10. Pace Analytical Services LLC

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology

Recommendations

Healthcare

Medical Device Technology Market

September 2024

REP-GB-423

Upcoming

Explore Healthcare Insights

View Reports
Future Market Insights

Preclinical Medical Device Testing Services Market